Buying Buzz: MannKind Corporation [MNKD] EVP Endocrine Business Unit Galindo Alejandro purchases 5,000 shares of the company

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. MannKind Corporation shares valued at $14,650 were purchased by Galindo Alejandro on Jul 31. At $2.93 per share, Galindo Alejandro acquired 5,000 shares. The insider’s holdings grew to 781,690 shares worth approximately $3.35 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Also, Tross Stuart A purchased 4,581 shares, netting a total of over 13,422 in proceeds. Following the buying of shares at $2.93 each, the insider now holds 830,650 shares.

Before that, Binder Steven B. had added 791 shares to its account. In a trade valued at $2,318, the Chief Financial Officer bought MannKind Corporation shares for $2.93 each. Upon closing the transaction, the insider’s holdings increased to 791 shares, worth approximately $3.13 million.

As published in their initiating research note from RBC Capital Mkts on May 14, 2021, MannKind Corporation [MNKD] has been a Sector perform and the price target has been revised to $5. This represents a 14.2% premium over Thursday’s closing price. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in late December. As of October 25, 2019, Cantor Fitzgerald has initiated its “an Overweight” rating for MNKD. Earlier on May 14, 2019, BTIG Research initiated its rating. Their recommendation was “a Buy” for MNKD stock.

Analyzing MNKD’s Price Performance

On Thursday, MannKind Corporation [NASDAQ: MNKD] rose 4.63% to $4.29. The stock’s lowest price that day was $4.09, but it reached a high of $4.295 in the same session. During the last five days, there has been a surge of approximately 22.57%. Over the course of the year, MannKind Corporation shares have dropped approximately -1.83%. Shares of the company reached a 52-week high of $4.86 on 06/08/22 and a 52-week low of $2.49 on 02/28/22. A 50-day SMA is recorded $3.96, while a 200-day SMA reached $3.92. Nevertheless, trading volume fell to 3.63 million shares from 5.39 million shares the previous day.

Support And Resistance Levels for MannKind Corporation (MNKD)

According to the 24-hour chart, there is a support level at 4.16, which, if violated, would cause prices to drop to 4.02. In the upper region, resistance lies at 4.36. The next price resistance is at 4.43. RSI (Relative Strength Index) is 63.79 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.44, which suggests the price will decrease in the coming days. Percent R is at 0.50%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Is MannKind Corporation subject to short interest?

Stocks of MannKind Corporation saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.79 million shares to 28.84 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 28.05 million shares. A jump of 2.74% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.52 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.52.

Which companies own the most shares of MannKind Corporation (MNKD)?

According to BlackRock Fund Advisors filings, the company currently owns 17,852,175 shares, which is about 7.07% of the total MNKD shares outstanding. The investor’s shares have plunged by -254,103 from its previous 13-F filing of 18106278.0 shares. With the completion of the buy transaction, SSgA Funds Management, Inc.’s stake is now worth $56,023,128. The Vanguard Group, Inc. acquire a 1.26% interest valued at $47.19 million while Avoro Capital Advisor LLC sold a 0 stake. A total of 1,157 shares of MannKind Corporation were sold by Fidelity Management & Research Co during the quarter, and -680,058 were sold by Emerald Advisers LLC. In its current portfolio, Geode Capital Management LLC holds 4,534,505 shares valued at $17.28 million.

In terms of MannKind Corporation share price expectations, FactSet research, analysts set an average price target of $6.00 in the next 12 months, up nearly 40.24% from the previous closing price of $4.10. Analysts anticipate MannKind Corporation stock to reach $8.00 by 2022, with the lowest price target being $5.00. In spite of this, 6 analysts ranked MannKind Corporation stock as a Buy at the end of 2022. On March 04, 2019, SVB Leerink assigned a price target of “an Outperform” to the stock and initiated coverage with a $3.


Please enter your comment!
Please enter your name here